Immunovant, Inc. 4

COO Melanie Gloria sold 2,036 shares of Immunovant, Inc. common stock around $39.5–$40 per share to cover taxes from RSU vesting, retaining 222,357 shares afterward.

On July 8, 2026, Immunovant, Inc. Chief Operating Officer Melanie Gloria sold a total of 2,036 shares of Immunovant common stock in two small, open-market transactions at weighted average prices of approximately $39.53 and $39.99 per share, respectively, solely to cover tax withholding obligations related to the July 1, 2026 vesting and settlement of previously granted restricted stock units. These mandated "sell to cover" trades, executed over price ranges disclosed in the footnotes, reduced her directly held position only modestly, leaving her with 222,357 shares of common stock owned directly after the transactions.

Filing Facts

CIK

1764013

Ticker

IMVT

Form

4

Source Type

fda

Accession

0001764013-26-000083

Alert Tier

5